دورية أكاديمية
Autotransplantation of Unmanipulated Bone Marrow into Scarred Myocardium is Safe and Enhances Cardiac Function in Humans
| العنوان: | Autotransplantation of Unmanipulated Bone Marrow into Scarred Myocardium is Safe and Enhances Cardiac Function in Humans |
|---|---|
| المؤلفون: | Manuel Galiñanes, Mahmoud Loubani, Joan Davies, Derek Chin, John Pasi, Peter R. Bell |
| المصدر: | Cell Transplantation, Vol 13 (2004) |
| بيانات النشر: | SAGE Publishing, 2004. |
| سنة النشر: | 2004 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | Medicine |
| الوصف: | Stem cell transplants into damaged myocardium may have the potential to improve cardiac function. We investigated the safety of transplanting unmanipulated autologous bone marrow into infarcted myocardium of patients undergoing coronary bypass surgery and assessed its efficacy to improve cardiac function. Fourteen patients with one or more areas of transmural myocardial infarction were studied. Autologous bone marrow was obtained by sternal bone aspirate at the time of surgery, diluted in autologous serum at a ratio of 1:2, and then injected 1 cm apart into the mid-depth of the left ventricular scar. There were no deaths, no perioperative myocardial infarctions, and no significant ventricular arrhythmias. Dobutamine stress echocardiography demonstrated overall improvement in the global and regional left ventricular function 6 weeks and 10 months after surgery. Of 34 infarcted left ventricular segments, 11 were injected with bone marrow alone, 13 were revascularized with a bypass graft alone, and 10 received bone marrow transplantation and a bypass graft in combination. Only the left ventricle segmental wall motion score of the areas injected with bone marrow and receiving a bypass graft in combination improved at low dose and at peak dobutamine stress. These findings suggest that transplantation of unmanipulated autologous bone marrow into scar tissue of the human heart is safe and enhances cardiac function only when used in combination with myocardial revascularization. This benefit can be seen after 6 weeks of the bone marrow transplant and is maintained after 10 months of follow-up. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 0963-6897 1555-3892 00000000 |
| العلاقة: | https://doaj.org/toc/0963-6897Test; https://doaj.org/toc/1555-3892Test |
| DOI: | 10.3727/000000004772664842 |
| الوصول الحر: | https://doaj.org/article/a9d57cc1a3fa45da9c73aa825729b8eaTest |
| رقم الانضمام: | edsdoj.9d57cc1a3fa45da9c73aa825729b8ea |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 09636897 15553892 00000000 |
|---|---|
| DOI: | 10.3727/000000004772664842 |